|16th February 2021||Joseph P Hagan||4,144||Open or private sale||$1.72||$7,127.68|
|14th August 2020||Joseph P Hagan||4,245||Open or private sale||$0.60||$2,567.80|
|25th June 2020||Joseph P Hagan||7,500||Grant/award etc.||$0.00|
|25th June 2020||John Peter Walker||7,500||Grant/award etc.||$0.00|
|25th June 2020||Steven Lo||146,250||Grant/award etc.||$0.00|
|25th June 2020||Kenneth Greathouse||7,500||Grant/award etc.||$0.00|
|25th June 2020||Donald J Kellerman||18,750||Grant/award etc.||$0.00|
|25th June 2020||Hayley Lewis||18,750||Grant/award etc.||$0.00|
|25th June 2020||Kleanthis G Xanthopoulos||7,500||Grant/award etc.||$0.00|
|25th June 2020||Linda S Grais||7,500||Grant/award etc.||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
Zosano Pharma Corp. is a clinical stage pharmaceutical company. It engages in the provision of systemic administration of therapeutics to patients. The company was founded in January 2012 and is headquartered in Fremont, CA.